Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koch Industries, through its various subsidiaries and divisions like Koch Chemical Company, is a major infrastructure and technology provider to the global life sciences and healthcare sectors. The company is a dominant player in the medical device and drug delivery space through its ownership of Phillips-Medisize, a leading contract development and manufacturing organization (CDMO) that specializes in complex drug delivery systems, including injectables and inhalers. Additionally, Koch Separation Solutions provides critical membrane filtration and separation technologies essential for biopharmaceutical downstream processing and purification. Through its venture arm, Koch Disruptive Technologies, the organization also makes significant strategic investments in innovative biotech and medtech firms, ranging from synthetic biology to advanced medical imaging. While not a traditional drug developer, Koch provides the manufacturing scale, technological platforms, and capital necessary for the commercialization of modern therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koch Chemical Company.